Figure 2.

Results from qualitative PCR showing amplification of the hematopoetic stem cell marker CD34 in ESC cells treated (a) without LIF, (b) with BMP-2, or (c) DAG. Beta-actin was used as control.

Handschel et al. Head & Face Medicine 2008 4:10   doi:10.1186/1746-160X-4-10
Download authors' original image